Leaflet MODERIBA 400mg film-coated tablets
Indicated for: chronic hepatitis C
Route of administration: oral
Substance: ribavirin (antiviral)
ATC: J05AB04 (Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
Ribavirin is an antiviral medication used in the treatment of chronic hepatitis C and other severe viral infections. It works by inhibiting viral replication, reducing the viral load in the body.
The medication is taken orally, as directed by a doctor, usually in combination with other antiviral drugs such as interferon. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the therapy's effectiveness.
Patients should be aware of potential side effects, such as anemia, fatigue, or skin irritation. It is important to inform the doctor of any unusual symptoms.
Common side effects include anemia, fatigue, and skin irritation. In rare cases, severe reactions such as depression or liver dysfunction may occur. Patients should be informed of these risks before use.
General data about MODERIBA 400mg
- Substance: ribavirin
- Date of latest medicines list: 01-05-2018
- Product code: W61969001
- Concentration: 400mg
- Pharmaceutical form: film-coated tablets
- Quantity: 56
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for ribavirin
Concentrations available for ribavirin
- 200mg
- 400mg
- 40mg/ml
- 600mg